Birdwatch Note Rating
2023-04-03 21:29:43 UTC - NOT_HELPFUL
Rated by Participant: 6DD62212B01DF312B800E4630181D7FD90E29515B84D8D6EAC4F74D51B3B8ACF
Participant Details
Original Note:
Three doses of BNT162b2 have a vaccine effectiveness of 73.5% against mild or moderate disease in adults aged 20–59 years, 98.6% protection against severe disease https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext#tbl2 The 3-dose VE against hospitalization was 97.5%, 82.0%, and 72.4%, respectively. https://www.medrxiv.org/content/10.1101/2022.09.30.22280573v2
All Note Details